TY  - JOUR
AU  - Zitricky, Frantisek
AU  - Försti, Asta
AU  - Hemminki, Akseli
AU  - Hemminki, Kari
TI  - Conditional survival in breast cancer up to 10 years in the Nordic countries.
JO  - Cancer medicine
VL  - 12
IS  - 17
SN  - 2045-7634
CY  - Hoboken, NJ
PB  - Wiley
M1  - DKFZ-2023-01654
SP  - 17945-17951
PY  - 2023
N1  - #LA:C020# / 2023 Sep;12(17):17945-17951
AB  - Survival in breast cancer (BC) has developed favorably but late recurrences are still a problem.We model survival data from the NORDCAN database and analyze 1-, 5-, and 10-year relative survival and 5/1- and 10/5-year conditional survival in BC from Denmark (DK), Finland (FI), Norway (NO), and Sweden (SE) between 1971 and 2020. Conditional survival measures survival in those who had survived year 1 to reach year 5 (5/1), or in those who had survived year 5 to reach year 10 (10/5).Almost all survival metrics were best for SE but survival in all countries improved in the course of time approaching the SE levels which were 98.3
KW  - conditional survival (Other)
KW  - metastasis (Other)
KW  - periodic survival (Other)
KW  - recurrence (Other)
KW  - screening (Other)
KW  - treatment (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37578395
DO  - DOI:10.1002/cam4.6436
UR  - https://inrepo02.dkfz.de/record/278420
ER  -